Sermet Sağol
Research Subjects
Research Interests
Sermet Sağol has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Erhan Parıltay
Department of Medical Genetics, Faculty of Medicine, Ege University, İzmir, Turkey
2 shared publications - Ferda Özkınay
Medical School of Ege University, Division of Infectious Disease, Department of Pediatrics, Izmir, Turkey
2 shared publications - Ozgur Cogulu
Department of Pediatric Genetics, Faculty of Medicine, Ege University, Izmir, Turkey
2 shared publications - Aslı Ece SOLMAZ
Department of Medical Genetics , Faculty of Medicine, Ege University, İzmir, Türkiye
1 shared publication - Asude Durmaz
Department of Medical Genetics, Ege University Faculty of Medicine, Izmir, Türkiye
1 shared publication - Ayca Aykut
Department of Medical Genetics, Ege University Faculty of Medicine, Izmir, Türkiye
1 shared publication
Latest Publications
- Open Access
- 10 June 2024
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (2) , 177-183
Türk Popülasyonunda MMP2 ve MMP9 Değişimlerinin Spontan Abortus Etiyolojisindeki Rolü
Amaç: Embriyo implantasyonu ve plasental dolaşımın temel sorumlusu olan kapiller damarlardaki patolojilerin abortus etiyolojisindeki mekanizmalar üzerinde etkileri olduğu bilinmektedir. Matriks metalloproteinaz (MMP) ailesinden MMP2 ve MMP9’un ekstrasellüler matriks organizasyonunda ve trofoblast implantasyonunda önemli görevleri vardır. Bu çalışmada, fonksiyonel olduğu bilinen MMP2 -735 C>T, -1306 C>T ve MMP9 -1562 C>T polimorfizmlerinin spontan abortus (SA) materyallerindeki genotip farklılıklarını belirlemek ve bu polimorfizmlerin SA etiyolojisinde rolü olup olmadığına ışık tutabilmek amaçlanmıştır. Gereç ve Yöntem: Polimorfizmlerin genotiplerinin analizinde restriksiyon fragman uzunluk polimorfizmi (RFLP) yöntemi kullanılmıştır. Çalışma grubu 80 spontan abortus örneğinden, kontrol grubu 100 sağlıklı gönüllü bireyin periferik kan örneğinden oluşmaktadır. Bulgular: MMP2 -735 C>T ve MMP9 -1562 C>T polimorfizmleri için SA örnekleri ve kontrol grubu arasında anlamlı fark saptanmadı. MMP2 -1306 C>T polimorfizminin heterozigot genotip sıklığı SA örneklerinde kontrol grubuna kıyasla 2,2 kat daha fazla bulundu (p=0.043). MMP2 genindeki normal -735 C>T ve heterozigot -1306 C>T genotiplerinin birlikte görülme sıklığı SA örneklerinde kontrol grubuna göre 3,7 kat fazla idi (p=0.021). Sonuç: MMP2 -1306 C>T fonksiyonel polimorfizmi ile SA oluşması arasında bir ilişki bulunmuştur. Daha yüksek sayılardaki SA çalışmalarındaki ileri genetik çalışmalar ve ekspresyon analizleri MMP2 ve MMP9 polimorfizmlerinin SA üzerindeki potansiyel rollerini net olarak belirlemede katkıda bulunacaktır.
- 10 June 2024
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (2) , 177-183
Open AccessTürk Popülasyonunda MMP2 ve MMP9 Değişimlerinin Spontan Abortus Etiyolojisindeki Rolü
Amaç: Embriyo implantasyonu ve plasental dolaşımın temel sorumlusu olan kapiller damarlardaki patolojilerin abortus etiyolojisindeki mekanizmalar üzerinde etkileri olduğu bilinmektedir. Matriks metalloproteinaz (MMP) ailesinden MMP2 ve MMP9’un ekstrasellüler matriks organizasyonunda ve trofoblast implantasyonunda önemli görevleri vardır. Bu çalışmada, fonksiyonel olduğu bilinen MMP2 -735 C>T, -1306 C>T ve MMP9 -1562 C>T polimorfizmlerinin spontan abortus (SA) materyallerindeki genotip farklılıklarını belirlemek ve bu polimorfizmlerin SA etiyolojisinde rolü olup olmadığına ışık tutabilmek amaçlanmıştır. Gereç ve Yöntem: Polimorfizmlerin genotiplerinin analizinde restriksiyon fragman uzunluk polimorfizmi (RFLP) yöntemi kullanılmıştır. Çalışma grubu 80 spontan abortus örneğinden, kontrol grubu 100 sağlıklı gönüllü bireyin periferik kan örneğinden oluşmaktadır. Bulgular: MMP2 -735 C>T ve MMP9 -1562 C>T polimorfizmleri için SA örnekleri ve kontrol grubu arasında anlamlı fark saptanmadı. MMP2 -1306 C>T polimorfizminin heterozigot genotip sıklığı SA örneklerinde kontrol grubuna kıyasla 2,2 kat daha fazla bulundu (p=0.043). MMP2 genindeki normal -735 C>T ve heterozigot -1306 C>T genotiplerinin birlikte görülme sıklığı SA örneklerinde kontrol grubuna göre 3,7 kat fazla idi (p=0.021). Sonuç: MMP2 -1306 C>T fonksiyonel polimorfizmi ile SA oluşması arasında bir ilişki bulunmuştur. Daha yüksek sayılardaki SA çalışmalarındaki ileri genetik çalışmalar ve ekspresyon analizleri MMP2 ve MMP9 polimorfizmlerinin SA üzerindeki potansiyel rollerini net olarak belirlemede katkıda bulunacaktır.
- Open Access
- 24 April 2024
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- Vol. 30 (1) , 1-13
Transplantation and Pregnancy
Transplantation is becoming increasingly widespread worldwide as a life-saving treatment for patients with end-stage organ failure. While the woman's quality of life improves rapidly after transplantation, the improvement of the endocrine system helps to regain fertility. The success of conception and successful pregnancy rates are quite low compared to the general population. Particular attention should be paid to obstetric complications such as hypertension, preeclampsia, fetal growth restriction, and preterm delivery during pregnancy. Ideally, preconception counseling should begin in the period before transplantation. Initiating contraception immediately after transplantation is ideal and long-acting reversible methods such as intrauterine devices and subcutaneous implants may be preferable. Factors that influence pregnancy outcomes in women undergoing organ transplantation include good general health within two years of transplantation, no evidence of organ rejection in the last year, stable graft conditions, absence of acute infections affecting the fetus, and adequate doses of immunosuppression drugs. However, factors that may adversely affect pregnancy include the etiology of the disease requiring transplantation, chronic allograft dysfunction, renal failure, cardiopulmonary diseases, hypertension, diabetes, obesity, and infections such as hepatitis B, hepatitis C, and Cytomegalovirus (CMV). Postponing pregnancy for at least 1 year after transplantation is very important to optimize pregnancy outcomes. Pregnancy in the early post-transplant period increases the risk of acute rejection, infection risk, and graft-related problems. In general, transplanted women can have successful pregnancies and live birth rates are above 70% on average. Although perinatal morbidity and mortality rates are high, most newborns are healthy and develop normally. Specific criteria such as pre-pregnancy serum creatinine levels and blood pressure control, as well as adherence to immunosuppressive therapy, significantly influence pregnancy success in transplant patients. In this review, optimizing pregnancy outcomes often involves addressing maternal and fetal risks, regular graft monitoring to detect potential complications such as organ rejection, and regulation of transplant medications to ensure safety and efficacy during pregnancy. Successful management relies on a multidisciplinary approach with contributions from obstetricians, neonatologists, nephrologists, hepatologists, and transplant surgeons.
- 24 April 2024
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- Vol. 30 (1) , 1-13
Open AccessTransplantation and Pregnancy
Transplantation is becoming increasingly widespread worldwide as a life-saving treatment for patients with end-stage organ failure. While the woman's quality of life improves rapidly after transplantation, the improvement of the endocrine system helps to regain fertility. The success of conception and successful pregnancy rates are quite low compared to the general population. Particular attention should be paid to obstetric complications such as hypertension, preeclampsia, fetal growth restriction, and preterm delivery during pregnancy. Ideally, preconception counseling should begin in the period before transplantation. Initiating contraception immediately after transplantation is ideal and long-acting reversible methods such as intrauterine devices and subcutaneous implants may be preferable. Factors that influence pregnancy outcomes in women undergoing organ transplantation include good general health within two years of transplantation, no evidence of organ rejection in the last year, stable graft conditions, absence of acute infections affecting the fetus, and adequate doses of immunosuppression drugs. However, factors that may adversely affect pregnancy include the etiology of the disease requiring transplantation, chronic allograft dysfunction, renal failure, cardiopulmonary diseases, hypertension, diabetes, obesity, and infections such as hepatitis B, hepatitis C, and Cytomegalovirus (CMV). Postponing pregnancy for at least 1 year after transplantation is very important to optimize pregnancy outcomes. Pregnancy in the early post-transplant period increases the risk of acute rejection, infection risk, and graft-related problems. In general, transplanted women can have successful pregnancies and live birth rates are above 70% on average. Although perinatal morbidity and mortality rates are high, most newborns are healthy and develop normally. Specific criteria such as pre-pregnancy serum creatinine levels and blood pressure control, as well as adherence to immunosuppressive therapy, significantly influence pregnancy success in transplant patients. In this review, optimizing pregnancy outcomes often involves addressing maternal and fetal risks, regular graft monitoring to detect potential complications such as organ rejection, and regulation of transplant medications to ensure safety and efficacy during pregnancy. Successful management relies on a multidisciplinary approach with contributions from obstetricians, neonatologists, nephrologists, hepatologists, and transplant surgeons.
- Open Access
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 1775-1780
20-year experience on prenatal diagnosis in a reference university medical genetics center in Turkey
Background/aim: Although cutting edge procedures such as cell-free fetal DNA isolation from maternal blood are now available, invasive prenatal tests are still being used extensively for prenatal diagnosis. The study aims to evaluate the demographic data, indications, and cytogenetic results of 9297 results of patients who underwent prenatal invasive testing for genetic analysis that were referred for the last 20 years in a University Medical Genetics Center. Materials and methods: The records of 8363 amniocenteses, 626 chorionic villus, and 308 cordocenteses samples were retrospectively evaluated and analyzed regarding referral reasons, indications and their cytogenetic results. The total numbers and the percentages of each group were recorded; Chi-square and logistic regression analyses were performed to give the statistical likelihood of different events. Results: The number of referrals decreased significantly after 2009. Risk of having trisomy 21 as well as trisomy 13 and 18 significantly increased in parallel with advanced maternal age. When the 21-25 age group was compared to the older age groups in terms of having a trisomy 21 pregnancy, the risk doubled in the 36-40, 5 times higher in 41-45 and 10-fold in 46-50 age groups. No significant linear correlation between maternal serum screening test results and trisomy 21 was found, however the difference between the pregnancies whom cut-off value above and below 1/250 in maternal serum screening test were significant. Conclusion: These data have provided useful information on the frequency of referrals to the reference genetics department, and the feasibility of genetic services. By reviewing the indications and their corresponding results, we can offer invaluable insights that will be useful in genetic counseling and also in the development of more effective genetic strategies.
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 1775-1780
Open Access20-year experience on prenatal diagnosis in a reference university medical genetics center in Turkey
Background/aim: Although cutting edge procedures such as cell-free fetal DNA isolation from maternal blood are now available, invasive prenatal tests are still being used extensively for prenatal diagnosis. The study aims to evaluate the demographic data, indications, and cytogenetic results of 9297 results of patients who underwent prenatal invasive testing for genetic analysis that were referred for the last 20 years in a University Medical Genetics Center. Materials and methods: The records of 8363 amniocenteses, 626 chorionic villus, and 308 cordocenteses samples were retrospectively evaluated and analyzed regarding referral reasons, indications and their cytogenetic results. The total numbers and the percentages of each group were recorded; Chi-square and logistic regression analyses were performed to give the statistical likelihood of different events. Results: The number of referrals decreased significantly after 2009. Risk of having trisomy 21 as well as trisomy 13 and 18 significantly increased in parallel with advanced maternal age. When the 21-25 age group was compared to the older age groups in terms of having a trisomy 21 pregnancy, the risk doubled in the 36-40, 5 times higher in 41-45 and 10-fold in 46-50 age groups. No significant linear correlation between maternal serum screening test results and trisomy 21 was found, however the difference between the pregnancies whom cut-off value above and below 1/250 in maternal serum screening test were significant. Conclusion: These data have provided useful information on the frequency of referrals to the reference genetics department, and the feasibility of genetic services. By reviewing the indications and their corresponding results, we can offer invaluable insights that will be useful in genetic counseling and also in the development of more effective genetic strategies.